• circHIF1A/miR-486-5p/GRHL2 Axis Drives LUAD Progression via

  2026-04-28

  This study identifies the circHIF1A/miR-486-5p/GRHL2 regulatory axis as a driver of macrophage M2 polarization and immunosuppressive microenvironment formation in lung adenocarcinoma. The research leverages circular RNA analysis to reveal new mechanisms and potential biomarkers for disease progression and prognosis.

• Leupeptin Hemisulfate Salt: Precision Protease Regulation in

  2026-04-28

  Leupeptin hemisulfate salt stands as a gold-standard, reversible inhibitor for precise regulation of serine and cysteine proteases in protein degradation and viral replication studies. This article demystifies advanced experimental workflows, troubleshooting tactics, and the latest protocol innovations for maximizing reproducibility and data reliability.

• HDAC8-Mediated AKT Activation Drives Resistance to MEK1/2 In

  2026-04-27

  This study uncovers an HDAC8-driven mechanism that enables cancer cells to evade MEK1/2-targeted therapies by activating AKT signaling through upregulation of PLCB1 and suppression of DESC1. The findings highlight novel molecular targets to overcome resistance in cancers with NRAS/BRAF mutations, offering guidance for future pathway inhibition strategies.

• BMS-345541 Hydrochloride: Advanced IKK Inhibitor for Inflamm

  2026-04-27

  BMS-345541 hydrochloride stands out as a highly selective IKK inhibitor, empowering researchers to precisely dissect NF-κB signaling in inflammation and cancer biology. Its unique solubility, robust selectivity, and proven in vitro and in vivo efficacy streamline experimental workflows and boost data reliability.

• AG-490 (Tyrphostin B42): Precision Modulation of JAK2/STAT6

  2026-04-26

  Explore the advanced use of AG-490 (Tyrphostin B42) in dissecting JAK2/STAT6-driven macrophage polarization and tumor microenvironment modulation. This article combines mechanistic insights with actionable guidance for optimizing immunopathological research.

• Applied Research with Ertugliflozin (PF-04971729): Protocols

  2026-04-25

  Ertugliflozin (PF-04971729) enables high-selectivity SGLT2 inhibition for diabetes, cardiovascular, and inflammation models. This guide details robust workflows, troubleshooting strategies, and translates novel cardioprotection findings into actionable experimental design.

• Acetoacetic Acid Sodium Salt: Protocol Advances in Energy Me

  2026-04-24

  Acetoacetic acid sodium salt emerges as a benchmark tool for probing fatty acid catabolism pathways and diagnosing metabolic imbalance in translational diabetes research. This guide distills experimental workflows, troubleshooting strategies, and the latest cross-domain insights to help researchers maximize reproducibility and clinical relevance.

• METTL14 and Thiamine Modulate Diabetes Therapy via m6A Regul

  2026-04-24

  This study identifies the epigenetic regulator METTL14 as a mediator of thiamine’s impact on intensive insulin therapy in diabetes, uncovering how m6A modification shapes metabolic gene expression. The integration of transcriptomic, MeRIP-seq, and RT-qPCR data reveals actionable molecular targets for improving glycemic and lipid outcomes in diabetic patients.

• Wortmannin: PI3K Inhibitor Workflows for Cancer and Viral En

  2026-04-23

  Wortmannin stands out as a benchmark PI3K inhibitor, enabling mechanistic dissection of PI3K/Akt/mTOR signaling in cancer, apoptosis, and autophagy studies. Its proven efficacy in both oncology and novel antiviral models makes it indispensable for researchers seeking robust, selective pathway inhibition.

• Amitriptyline HCl (B2231): Technical Guidance for Lab Resear

  2026-04-23

  Amitriptyline HCl (SKU B2231) is a high-purity, well-characterized compound used for precise modulation of multiple neurotransmitter receptors in neuropharmacology research. It is most suitable for workflows demanding reliable serotonin/norepinephrine receptor inhibition, but should not be used where long-term solution stability is required due to its sensitivity. Researchers benefit from its defined solubility, storage, and QC parameters.

• Bovine Insulin (SKU A5981): Reliable Cell Culture Performanc

  2026-04-22

  This article explores how Bovine Insulin (SKU A5981) from APExBIO addresses real-world challenges in cell viability and proliferation assays. By grounding recommendations in quantitative data, peer-reviewed literature, and validated workflows, we demonstrate the product’s role in ensuring consistent, reproducible results for biomedical research applications.

• Veratridine: Voltage-Gated Sodium Channel Opener in Neurobio

  2026-04-22

  Veratridine is a potent voltage-gated sodium channel opener used as a research tool in sodium channel dynamics and excitotoxicity studies. This article details its mechanism, benchmarks, and precise application protocols for neuroscience and oncology workflows.

• Asunaprevir (BMS-650032): Optimizing HCV Protease Assays

  2026-04-21

  Asunaprevir (BMS-650032) sets the standard for robust, genotype-spanning HCV NS3 protease inhibition in translational and cell-based workflows. This guide details practical protocols, troubleshooting strategies, and evidence-driven insights to streamline antiviral research using APExBIO's trusted reagent.

• Vemurafenib (PLX4032): BRAF V600E Inhibitor for Melanoma Res

  2026-04-21

  Vemurafenib (PLX4032) is a potent, selective BRAF V600E inhibitor essential for dissecting MAPK signaling and resistance in melanoma research. Its robust inhibition of mutant BRAF enables precise control of cell proliferation in preclinical models. This dossier presents protocol parameters, resistance mechanisms, and best practices for integrating Vemurafenib into cancer biology workflows.

• PD0325901 MEK Inhibitor: Precision Tools for Pathway Control

  2026-04-20

  PD0325901, a highly selective MEK inhibitor from APExBIO, empowers researchers with precise regulation of RAS/RAF/MEK/ERK signaling for cancer and stem cell studies. This guide delivers best practices for experimental design, troubleshooting, and leveraging new insights into telomerase regulation.

8608 records 14/574 page Previous Next First page 上5页 1112131415 下5页 Last page